Medtronic PLC (NYSE: MDT) has reported earnings for its second fiscal quarter (ending October 31) of $0.99 versus $0.68 for the same period a year ago — an increase of 46%. For the latest four quarters through October 31, E.P.S. were $3.27 compared to $3.09 a year ago — an increase of 6%.
Recent Price Action
On 11/19/24, Medtronic PLC (NYSE: MDT) stock declined by -3.0%, closing at $85.00. Moreover, unusually high trading volume at 154% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -3.7% during the last week.
Current PriceTarget Research Rating
Medtronic has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Medtronic has a neutral Appreciation Score of 41 and a neutral Power Rating of 53, triggering the Low Neutral Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment